These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32479615)

  • 1. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care.
    Otter JA; Mookerjee S; Davies F; Bolt F; Dyakova E; Shersing Y; Boonyasiri A; Weiße AY; Gilchrist M; Galletly TJ; Brannigan ET; Holmes AH
    J Antimicrob Chemother; 2020 Sep; 75(9):2670-2676. PubMed ID: 32479615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.
    Park SH; Yi Y; Suh W; Ji SK; Han E; Shin S
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):62. PubMed ID: 37400884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving epidemiology of carbapenemase-producing Enterobacterales: one hospital's infection prevention and control response over nine years.
    Foley M; Duffy F; Skally M; McCormack F; Finn C; O'Connor M; Cafferkey J; Thomas T; Burns K; Fitzpatrick F; O'Connell K; Smyth EG; Humphreys H
    J Hosp Infect; 2021 Jun; 112():61-68. PubMed ID: 33812939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.
    Bar Ilan M; Kjerulf A
    J Hosp Infect; 2023 Dec; 142():74-87. PubMed ID: 37802236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of carbapenemase producing Enterobacterales colonization and risk factor of clinical infection.
    Lee KH; Kim D; Hong JS; Park SY; Cho NH; Kim MN; Lee YJ; Wi Y; Lee EH; Han SH; Jeong SH; Song YG
    J Infect Public Health; 2023 Nov; 16(11):1860-1869. PubMed ID: 37837922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting.
    Pople D; Kypraios T; Donker T; Stoesser N; Seale AC; George R; Dodgson A; Freeman R; Hope R; Walker AS; Hopkins S; Robotham J
    BMC Med; 2023 Dec; 21(1):492. PubMed ID: 38087343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial impact of a national programme to contain the spread of carbapenemase-producing Enterobacterales in Ireland.
    Vellinga A; Brennan W; Humphreys H; Burns K
    J Hosp Infect; 2021 Mar; 109():107-114. PubMed ID: 33429000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
    J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
    Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
    J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients.
    Lemarié C; Legeay C; Mahieu R; Moal F; Ramont C; Kouatchet A; Eveillard M
    J Hosp Infect; 2021 Jun; 112():16-20. PubMed ID: 33636255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit and feedback as a tool to increase compliance with carbapenemase-producing Enterobacteriaceae (CPE) screening and decrease CPE transmission in the hospital.
    Ben Natan O; Stein M; Reisfeld S
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1788-1792. PubMed ID: 36081188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
    French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
    J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based Assessment of the Effect of Contact Precautions Applied to Surveillance-detected Carriers of Carbapenemase-producing Enterobacteriaceae in Long-term Acute Care Hospitals.
    Toth DJA; Khader K; Beams A; Samore MH
    Clin Infect Dis; 2019 Sep; 69(Suppl 3):S206-S213. PubMed ID: 31517974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: A retrospective cohort study.
    Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Pekovic V; Abbo LM; Martinez O; Rosello G; Sposato K; Doi Y; Trepka MJ
    Am J Infect Control; 2021 Oct; 49(10):1281-1286. PubMed ID: 34146625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
    Kardaś-Słoma L; Fournier S; Dupont JC; Rochaix L; Birgand G; Zahar JR; Lescure FX; Kernéis S; Durand-Zaleski I; Lucet JC
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):117. PubMed ID: 36117231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized algorithm with improved turnaround time for detection of carbapenemase-producing
    Ratnayake L; Ang HZ; Ong CH; Chan DSG
    J Med Microbiol; 2020 Feb; 69(2):228-232. PubMed ID: 31922949
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction.
    Lowman W; Marais M; Ahmed K; Marcus L
    J Hosp Infect; 2014 Oct; 88(2):66-71. PubMed ID: 25082751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
    Papafotiou C; Roussos S; Sypsa V; Bampali S; Spyridopoulou K; Karapanou A; Moussouli A; Samarkos M; Daikos GL; Psichogiou M
    J Antimicrob Chemother; 2022 Nov; 77(12):3331-3339. PubMed ID: 36203392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.
    Harris HC; Buckley AM; Spittal W; Ewin D; Clark E; Altringham J; Bentley K; Moura IB; Wilcox MH; Woodford N; Davies K; Chilton CH
    J Hosp Infect; 2021 Jul; 113():1-9. PubMed ID: 33932556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.